Seidai Sato

3.6k total citations · 1 hit paper
59 papers, 2.6k citations indexed

About

Seidai Sato is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Seidai Sato has authored 59 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Seidai Sato's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (33 papers), Lung Cancer Treatments and Mutations (10 papers) and Occupational and environmental lung diseases (8 papers). Seidai Sato is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (33 papers), Lung Cancer Treatments and Mutations (10 papers) and Occupational and environmental lung diseases (8 papers). Seidai Sato collaborates with scholars based in Japan, Canada and United States. Seidai Sato's co-authors include Eiji Hara, Naoko Ohtani, Yuichi Ishikawa, Hiroaki Kanda, Kenshiro Oshima, Shin Yoshimoto, Masahira Hattori, Kenya Honda, Yoichiro Iwakura and Koji Atarashi and has published in prestigious journals such as Nature, Nature Communications and PLoS ONE.

In The Last Decade

Seidai Sato

52 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

2013 1.7k citations Hiroaki Kanda, Seidai Sato et al. profile →

Peers

Countries citing papers authored by Seidai Sato

Since Specialization

Citations

This map shows the geographic impact of Seidai Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seidai Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seidai Sato more than expected).

Fields of papers citing papers by Seidai Sato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seidai Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seidai Sato. The network helps show where Seidai Sato may publish in the future.

Co-authorship network of co-authors of Seidai Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Seidai Sato. A scholar is included among the top collaborators of Seidai Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seidai Sato. Seidai Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serial Changes of Fractional Exhaled Nitric Oxide and Periostin in the Treatment Course of Cough Variant Asthma 2025 ·American Journal of Respiratory and Critical Care Medicine ·Yoshikazu Isomura, Masaki Hanibuchi, Seidai Sato, Atsushi Mitsuhashi, Tetsuya Kajimoto, Atsuro Saijo, Yasuhiko Nishioka	0
2	A favorable antitumor efficacy of sotorasib in a patient with KRAS G12C-mutated pulmonary large-cell neuroendocrine carcinoma 2025 ·International Cancer Conference Journal ·Keisuke Nakanishi, Hirokazu Ogino, (unknown), (unknown), (unknown), (unknown), Yutaka Morita, (unknown), (unknown), (unknown), Noriko Bando, Atsushi Mitsuhashi, Seidai Sato, Masaki Hanibuchi, Yasuhiko Nishioka	0
3	Clock pathway inhibitor overcomes tumor immune-exclusion via regulation of fibrocyte differentiation 2025 ·npj Precision Oncology ·Atsushi Mitsuhashi, Kazuya Koyama, Hirokazu Ogino, Ryota Matsuo, (unknown), (unknown), (unknown), (unknown), Yutaka Morita, (unknown), (unknown), Seidai Sato, Hiroshi Kawano, Hiroshi Nokihara, Yutaka Inagaki, Tsutomu Shinohara, Masaki Hanibuchi, Hiromitsu Takizawa, Yasuhiko Nishioka	1
4	A case of pleural mesothelioma with immunohistochemical staining positive for Krebs von den Lungen-6 2024 ·Respiratory Medicine Case Reports ·(unknown), Seidai Sato, (unknown), Takeshi Masuda, (unknown), Hirokazu Ogino, Hirohisa Ogawa, Masaki Hanibuchi, Noboru Hattori, Yasuhiko Nishioka	0
5	A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer 2023 ·Thoracic Cancer ·(unknown), Masaki Hanibuchi, Eiji Takeuchi, Takashi Haku, Takanori Kanematsu, Naoki Nishimura, Yuko Toyoda, Atsushi Mitsuhashi, Kenji Otsuka, Seidai Sato, Hisatsugu Goto, (unknown), Hirokazu Ogino, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka	2
6	Antipodoplanin antibody enhances the antitumor effects of CTLA‐4 blockade against malignant mesothelioma by natural killer cells 2023 ·Cancer Science ·(unknown), Atsushi Mitsuhashi, (unknown), Hirokazu Ogino, (unknown), (unknown), Hiroshi Nokihara, Seidai Sato, Tsutomu Shinohara, Masaki Hanibuchi, Shinji Abe, Mika K. Kaneko, Yukinari Kato, Yasuhiko Nishioka	3
7	A novel BRD4 degrader, ARV-825, attenuates lung fibrosis through senolysis and antifibrotic effect 2023 ·Respiratory Investigation ·Seidai Sato, Kazuya Koyama, Hirohisa Ogawa, (unknown), (unknown), Yuya Yamashita, (unknown), Hiroshi Kawano, Eiji Hara, Yasuhiko Nishioka	7
8	Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis 2023 ·Respiratory Investigation ·Yasuhiko Nishioka, Sakae Homma, Takashi Ogura, Seidai Sato, (unknown), Keisuke Tomii, Koichiro Kamio, Susumu Sakamoto, Yasunari Miyazaki, Hiromi Tomioka, Shu Hisata, Tomohiro Handa, Arata Azuma	7
9	Multidisciplinary treatment of skeletal muscle metastasis from lung cancer: A case of triceps muscle metastasis of lung squamous cell cancer 2021 ·Respiratory Medicine Case Reports ·(unknown), Seidai Sato, (unknown), (unknown), Hiroshi Nokihara, Yasuhiko Nishioka	0
10	Blockade of Pan-Fibroblast Growth Factor Receptors Mediates Bidirectional Effects in Lung Fibrosis 2020 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown), Seidai Sato, Kazuya Koyama, (unknown), Yajuan Chen, Hisatsugu Goto, (unknown), Hirohisa Ogawa, (unknown), Hiroshi Kawano, Yuko Toyoda, Hisanori Uehara, Yasuhiko Nishioka	8
11	Clinical features of interstitial pneumonia associated with systemic lupus erythematosus 2019 ·Respiratory Investigation ·Yuko Toyoda, Kazuya Koyama, Hiroshi Kawano, (unknown), (unknown), (unknown), (unknown), Seidai Sato, Yuya Yamashita, Naoki Takahashi, Hisatsugu Goto, Masahiko Azuma, Yasuhiko Nishioka	15
12	Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice 2018 ·PLoS ONE ·Masami Kishi, Yoshinori Aono, Seidai Sato, Kazuya Koyama, Momoyo Azuma, Shuichi Abe, Hiroshi Kawano, Jun Kishi, Yuko Toyoda, (unknown), Hirohisa Ogawa, Hisanori Uehara, Yasuhiko Nishioka	40
13	Therapeutic targets and early stage clinical trials for pulmonary fibrosis 2018 ·Expert Opinion on Investigational Drugs ·Seidai Sato, Toyoshi Yanagihara, Martin Kolb	17
14	Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis 2018 ·European Respiratory Journal ·Pierre‐Simon Bellaye, Chiko Shimbori, Toyoshi Yanagihara, David A. Carlson, Philip F. Hughes, Chandak Upagupta, Seidai Sato, (unknown), Timothy Haystead, Kjetil Ask, Martin Kolb	44
15	The Tyrosine Kinase Inhibitor TAS-115 Attenuates Bleomycin-induced Lung Fibrosis in Mice 2018 ·American Journal of Respiratory Cell and Molecular Biology ·Kazuya Koyama, Hisatsugu Goto, (unknown), (unknown), (unknown), Seidai Sato, Hiroshi Kawano, Yuko Toyoda, Hirohisa Ogawa, Sakae Homma, Yasuhiko Nishioka	17
16	Lysyl Oxidase–Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor-β1–induced Pulmonary Fibrosis 2017 ·American Journal of Respiratory Cell and Molecular Biology ·Pierre‐Simon Bellaye, Chiko Shimbori, Chandak Upagupta, Seidai Sato, Wei Shi, Jack Gauldie, Kjetil Ask, Martin Kolb	49
17	Ablation of the p16INK4a tumour suppressor reverses ageing phenotypes of klotho mice 2015 ·Nature Communications ·Seidai Sato, (unknown), Akiko Takahashi, Yoshinori Imai, Aki Hanyu, Atsushi Okuma, Masaki Takasugi, Kimi Yamakoshi, Hiroyuki Sorimachi, Hiroaki Kanda, Yuichi Ishikawa, Saburo Sone, Yasuhiko Nishioka, Naoko Ohtani, Eiji Hara	60
18	Role of Platelet-Derived Growth Factor/Platelet-Derived Growth Factor Receptor Axis in the Trafficking of Circulating Fibrocytes in Pulmonary Fibrosis 2014 ·American Journal of Respiratory Cell and Molecular Biology ·Yoshinori Aono, Masami Kishi, Yuki Yokota, Momoyo Azuma, Katsuhiro Kinoshita, (unknown), Seidai Sato, Hiroshi Kawano, Jun Kishi, Hisatsugu Goto, Hisanori Uehara, Keisuke Izumi, Yasuhiko Nishioka	68
19	SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model 2012 ·Respirology ·(unknown), Masaki Hanibuchi, Hisatsugu Goto, Takuya Kuramoto, (unknown), Soji Kakiuchi, Seidai Sato, Satoshi Sakaguchi, (unknown), Yasuhiko Nishioka, Shin‐ichi Akiyama, Saburo Sone	11
20	Nitrite/nitrate (NOx) levels and hemodynamics during septic shock 2000 ·Surgery Today ·Hajime Nakae, Shigeatsu Endo, Mitsuru Kikuchi, Yasuhiko Yamada, Masashi Shibata, Hiroyasu Ishikura, Takaya Tanaka, Go Wakabayashi, Takae Kawamura, Katsuya Inada, Seidai Sato	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact